Table 2.
Description | Parameter | Definition |
---|---|---|
Any screen k | ||
Number of women screened | n.scrk | see Table 1 |
Negative screening episodes | n.negk | |
Proportion of false negatives at screen k | ||
False negative NPIS | ||
False negative PIS | ||
False negative PIBC | ||
Any pre-cancer state | ||
Prevalent screen | ||
Screen-detected NPIS | SisP12(age)/(P11(age) + P12(age) + P13(age) + P14(age)) | |
Screen-detected PIS | SisP13(age)/(P11(age) + P12(age) + P13(age) + P14(age)) | |
Screen-detected PIBC | SinvP14(age)/(P11(age) + P12(age) + P13(age) + P14(age)) | |
Incident screen k | ||
Screen-detected NPIS | ||
Screen-detected PIS | ||
Screen-detected PIBC | ||
Monthly incidence of interval cancers in the first m months after screen k | ||
In-situ | ||
Invasive |
Age, age at first screen; NPIS, non-progressive in situ breast cancer; PIBC, preclinical invasive breast cancer; PIS, progressive in situ breast cancerl; t, screening interval.